-+ 0.00%
-+ 0.00%
-+ 0.00%

Lantern Pharma Reports Q2 2025 Net Loss of $4.33 Million, EPS at $0.40, Down from $4.96 Million Loss and $0.46 EPS in Q2 2024

Reuters·08/13/2025 20:17:36

Please log in to view news